Shinhung (004080.KS) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · South Korea · ISIN KR7004080008
Shinhung financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 101.76 bn KRW | 102.61 bn KRW |
| Gross profit | 30.93 bn KRW | 31.95 bn KRW |
| Operating income | 6.28 bn KRW | 7.09 bn KRW |
| EBIT | 7.53 bn KRW | 5.42 bn KRW |
| Net income | 5.23 bn KRW | 2.82 bn KRW |
| Diluted EPS – continuing operations | 553.38 KRW | 298.72 KRW |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shinhung
Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory products; and disposable needles, dental operatories, and autoclaves and X-ray equipment. The company also offers loan services for dentists. Shinhung Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
More stocks
- DeviceENG.CO.Ltd (187870.KQ)
- Zomedica Corp. (ZOMDF)
- Anterogen.Co.Ltd (065660.KQ)
- CURATIS N AG (CURN.SW)
- Perspective Therapeutics, Inc. (CATX)
- SPSoft Inc. (443670.KQ)
- AEWIN Technologies Co.Ltd. (3564.TWO)
- Patria Bank SA (PBK.RO)
- Pharmosa Biopharm Inc. (6875.TWO)
- Chin Hsin Environ Engineering Co., Ltd. (6951.TW)
- Unicycive Therapeutics, Inc. (UNCY)
- QUALITAS SEMICONDUCTOR CO. LTD. (432720.KQ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.